Eli Lilly Is Acquiring AtaiBeckley For Psychedelic Drug Development
Eli Lilly (NYSE: LLY) has entered into a new deal to acquire AtaiBeckley (NASDAQ: ATAI) for up to $3.5 billion.
Eli Lilly (NYSE: LLY) has entered into a new deal to acquire AtaiBeckley (NASDAQ: ATAI) for up to $3.5 billion.
AtaiBeckley develops and advances clinical-stage psychedelic-based and neuropharmacology therapies for mental health conditions, including treatment-resistant depression.
Base Carbon Inc. provides capital and expertise to develop high-quality carbon reduction projects, facilitating the voluntary carbon markets and supporting emission reduction.
Sunrise Energy Metals is developing the Sunrise Battery Materials Complex in New South Wales, Australia, to supply sustainable nickel, cobalt, and scandium for cleaner energy.
Helus Pharma develops neuroplastogen therapies and drug delivery technologies for psychiatric and neurological disorders with a clinical-stage neuroscience pipeline.
Bally's Corporation is a global casino-entertainment company with a growing omni-channel presence, operating 15 casinos across 10 states and various digital platforms.
PharmAla Biotech is a Canadian company specializing in the research, development, and manufacturing of clinical-grade MDMA and novel MDXX compounds.
Eos Energy (NASDAQ: EOSE) has been awarded a new multi-million dollar deal from the United States Department of War to support the Golden Dome.
Walden Robotics has successfully raised $300 million in a seed financing round valuing the company at $1.1 billion.
Elon Musk has personally acquire mobile power company APR Energy according to new filings with the Federal Trade Commission.
Shenzhen, China based humanoid robotics startup LimX has successfully raised approximately $200M USD in a pre-IPO financing round.
RoboStrategy (NASDAQ: BOT) has successfully raised $15.9M USD in a new equity financing round.
Nebius (NASDAQ: NBIS) has entered into a new deal for high performance computing with artificial intelligence startup Reflection AI for roughly $1 billion.
The markets and trends that matter, made simple.



Join top talent at the world's most respected institutions, companies, and venture capital funds.